Latest Breaking News On - Ddiscovery biology - Page 1 : comparemela.com

Monte Rosa Therapeutics Presents Preclinical Data at Digestive Disease Week 2024 Highlighting Therapeutic Potential of MRT-6160 in Inflammatory Bowel Disease

MRT-6160, a VAV1-directed molecular glue degrader , inhibits colitis disease progression and colon inflammation, lowers inflammatory mucosal cytokines, and reduces expression of IBD-associated genes.

Washington
United-states
Boston
Massachusetts
Cory-tromblee
Monte-rosa
Andrew-funderburk
Markus-warmuth
Monte-rosa-qu
Marisa-peluso
Nasdaq
Exchange-commission

Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates

Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Portugal
United-states
Lisbon
Lisboa
Washington
Seattle
American
Mark-litton
Sharay-setti
Hans-moebius
Rachel-lenington
Sherif-reda

Inflammation Specialist Named New Centre Head at Hudson Institute

Inflammation Specialist Named New Centre Head at Hudson Institute
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Australia
China
Melbourne
Victoria
Guangzhou
Guangdong
Elizabeth-hartland
National-health
Research-council
Eliza-hall-institute
Infectious-diseases-hudson-institute
Autoinflammatory-disease-laboratory

As obesity drugs soar, Mass. biotechs seek a slice of the market

Several biotechs in Mass. are seeking to elbow their way into the lucrative market, which is currently dominated by Denmark’s Novo Nordisk, which makes Wegovy and Ozempic, and Eli Lilly, which produces Mounjaro.

Cambridge
Cambridgeshire
United-kingdom
United-states
France
Denmark
Massachusetts
Hillerod
Hovedstaden
Boston
French
Lotte-bjerre-knudsen

Specific Biologics Announces Additional Investment and Appointment of Experienced Biotechnology Leader Steven Kanner, PhD, to the Board of Directors

Specific Biologics Announces Additional Investment and Appointment of Experienced Biotechnology Leader Steven Kanner, PhD, to the Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Berkeley
California
United-states
Boston
Massachusetts
Canada
Toronto
Ontario
Vancouver
British-columbia
Miami
Florida